These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8072943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK.
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM.
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [Abstract] [Full Text] [Related]

  • 10. The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients.
    Hann SK, Kim HI, Im S, Park YK, Cui J, Bystryn JC.
    J Dermatol Sci; 1993 Dec; 6(3):201-5. PubMed ID: 8136318
    [Abstract] [Full Text] [Related]

  • 11. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU.
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [Abstract] [Full Text] [Related]

  • 12. Cytolytic antibodies to melanocytes in vitiligo.
    Cui J, Arita Y, Bystryn JC.
    J Invest Dermatol; 1993 Jun; 100(6):812-5. PubMed ID: 8496621
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a complement-mediated inhibition and an antibody-dependent cellular cytotoxicity of dermal fibroblasts in alopecia areata.
    Abdel-Naser MB, Blume-Peytavi U, Abdel-Fatah A, Orfanos CE.
    Acta Derm Venereol; 1994 Sep; 74(5):351-4. PubMed ID: 7817669
    [Abstract] [Full Text] [Related]

  • 14. The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo.
    Austin LM, Boissy RE, Jacobson BS, Smyth JR.
    Clin Immunol Immunopathol; 1992 Aug; 64(2):112-20. PubMed ID: 1643744
    [Abstract] [Full Text] [Related]

  • 15. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
    Tembhre MK, Sharma VK, Sharma A, Chattopadhyay P, Gupta S.
    Clin Chim Acta; 2013 Sep 23; 424():27-32. PubMed ID: 23680073
    [Abstract] [Full Text] [Related]

  • 16. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
    Palermo B, Campanelli R, Garbelli S, Mantovani S, Lantelme E, Brazzelli V, Ardigó M, Borroni G, Martinetti M, Badulli C, Necker A, Giachino C.
    J Invest Dermatol; 2001 Aug 23; 117(2):326-32. PubMed ID: 11511311
    [Abstract] [Full Text] [Related]

  • 17. Vitiliginous vs pigmented skin response to intradermal administration of interferon gamma.
    Gilhar A, Aizen E, Ohana N, Etzioni A.
    Arch Dermatol; 1993 May 23; 129(5):600-4. PubMed ID: 8097622
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y, Tanemura A, Yang L, Itoi S, Wataya-Kaneda M, Murota H, Fujimoto M, Serada S, Naka T, Katayama I.
    Pigment Cell Melanoma Res; 2012 Mar 23; 25(2):219-30. PubMed ID: 22136309
    [Abstract] [Full Text] [Related]

  • 19. Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes.
    Li DG, Hu WZ, Ma HJ, Liu W, Yang QQ, Zhao G.
    Mol Med Rep; 2016 Aug 23; 14(2):1275-82. PubMed ID: 27277530
    [Abstract] [Full Text] [Related]

  • 20. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA, Mollet IG, De Schepper S, Tjin EP, Vermaelen K, Clark RA, Kupper TS, Luiten RM, Lambert J.
    Pigment Cell Melanoma Res; 2010 Jun 23; 23(3):375-84. PubMed ID: 20370855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.